Blaze Medical Devices aims to begin commercialization in 2015

Blaze Medical Devices is so close to generating its first revenues it can taste them.

The Ann Arbor-based life sciences firm is developing a new technology that helps maximize existing blood supplies in medical uses. The 8-year-old startup is aiming to make its first sales early next year.

"Now we have a fully operational prototype, or a Alpha unit, done," says David Weaver, CEO of Blaze Medical Devices.

Blaze Medical Devices has developed blood transfusion technology that enables medical professionals to optimize blood banking and transfusions through testing. Its tests assess the quality of stored blood and its laboratory instruments help facilitate blood research.

"Our competition for the most part is the status quo," Weaver says. "First in first out, depending on age."

Blaze Medical Devices now employs a team of five people, including three co-founders and two researchers. It has added a new researcher over the last year. Weaver expects to receive initial UL approval for a research iteration of the technology by the end of this year, setting the stage for the company’s first sales in early 2015.

"We're forecasting sales in the first quarter of next year for the R&D device," Weaver says.

Source: David Weaver, CEO of Blaze Medical Devices
Writer: Jon Zemke

Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.

Related Company

  • Blaze Medical Devices
    Ann Arbor MI Website
    Blaze Medical Devices, a start-up company developing a novel testing system to improve the efficacy of blood transfusions.